Chwen-Yuen Angie Chen, MD, FACP, FASAM, Co-Chair
Dr. Chen is currently Medical Director of Chemical Dependency Clinics in Primary Care at Stanford University. She is a board member of CSAM as chair of communications, Editor of the CSAM newsletter, and oversees the Test Taking Track Board Review Question Bank.
No relevant financial relationships to disclose.

Triveni DeFries, MD
Dr. DeFries is an Assistant Clinical Professor of Medicine at UCSF in the Department of Internal Medicine. She serves as the Associate Medical Director of the general internal medicine clinic at San Francisco General Hospital.
No relevant financial relationships to disclose.

Dustin DeYoung, MD
Dr. DeYoung, MD, is a psychiatrist for the University of California, Los Angeles (UCLA) Behavioral Health Associates and a research physician for the UCLA Department of Family Medicine.
Disclosure: BDH Pharma, LLC: Ownership Interest (stocks, stock options, or other ownership interest excluding diversified mutual funds)

Thomas W. Meeks, MD, FASAM
Dr. Meeks is Medical Director of the Addiction Recovery Treatment Services at the Sacramento VA Medical Center and Assistant Clinical Professor of Psychiatry at UC Davis.
No relevant financial relationships to disclose.

Marie A. Mulligan, MD
Dr. Mulligan has provided primary care to patients living with substance use disorders and their family members for more than twenty years. She worked at SRCH since 2006 providing primary care to primarily Spanish speaking and English-speaking patients, including those living with severe mental illness and homelessness.
No relevant financial relationships to disclose.

Deborah Stephenson, MD
Dr. Stephenson is boarded in Preventive Medicine & Public Health, and Addiction Medicine through the American Board of Addiction Medicine. She works as a Senior Staff Physician managing patients with opioid use disorder in an ambulatory care clinic, which houses an Opioid Treatment Program, a Perinatal Substance Abuse Program and a Medication Assisted Treatment program.
No relevant financial relationships to disclose.

John Tsuang, MD, MS
Dr. Tsuang is the director of the Dual Diagnosis Treatment Program at the Harbor/UCLA Medical Center. He is a Clinical Professor of Psychiatry at the UCLA School of Medicine.
No relevant financial relationships to disclose.

Mason Turner, MD, MS, Co-Chair
Mason Turner, MD, is a psychiatrist at the Maui Lani Medical Office. He served as director of outpatient mental health and addiction medicine for Kaiser Permanente Northern California.
No relevant financial relationships to disclose.